These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7954338

  • 1. A proteolytic activity in a human breast cancer cell line which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.
    Moy LY, Billings PC.
    Cancer Lett; 1994 Oct 14; 85(2):205-10. PubMed ID: 7954338
    [Abstract] [Full Text] [Related]

  • 2. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor.
    Billings PC, Habres JM, Liao DC, Tuttle SW.
    Cancer Res; 1991 Oct 15; 51(20):5539-43. PubMed ID: 1913672
    [Abstract] [Full Text] [Related]

  • 3. A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.
    Billings PC, Habres JM.
    Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):3120-4. PubMed ID: 1557421
    [Abstract] [Full Text] [Related]

  • 4. Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors.
    Habres JM, Billings PC.
    Cancer Lett; 1992 Apr 15; 63(2):135-42. PubMed ID: 1562990
    [Abstract] [Full Text] [Related]

  • 5. Identification of a soluble enzyme from C3H/10T1/2 cells which is inhibited by the Bowman-Birk proteinase inhibitor.
    Fagan JM, Waxman L.
    Biochem Biophys Res Commun; 1991 Aug 15; 178(3):856-61. PubMed ID: 1872865
    [Abstract] [Full Text] [Related]

  • 6. Proteolytic activities of mouse sarcoma 180 cells that are inhibited by Bowman-Birk and Kunitz protease inhibitors.
    Chu SC, Chou FP, Liu JY, Lin LJ, Hsieh YS.
    Biochem Mol Biol Int; 1997 Aug 15; 42(5):965-75. PubMed ID: 9285064
    [Abstract] [Full Text] [Related]

  • 7. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW, Huang SC, Lin-Shiau SY, Lin JK.
    Carcinogenesis; 2005 Jul 15; 26(7):1296-306. PubMed ID: 15746161
    [Abstract] [Full Text] [Related]

  • 8. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR.
    Nutr Cancer; 1999 Jul 15; 33(2):165-73. PubMed ID: 10368812
    [Abstract] [Full Text] [Related]

  • 9. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
    Billings PC, St Clair W, Owen AJ, Kennedy AR.
    Cancer Res; 1988 Apr 01; 48(7):1798-802. PubMed ID: 3280120
    [Abstract] [Full Text] [Related]

  • 10. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29.
    Fereidunian A, Sadeghalvad M, Oscoie MO, Mostafaie A.
    Arch Med Res; 2014 Aug 01; 45(6):455-61. PubMed ID: 25014623
    [Abstract] [Full Text] [Related]

  • 11. Proteases, protease inhibitors and radiation carcinogenesis.
    Kennedy AR.
    Int J Radiat Biol; 2023 Aug 01; 99(6):882-890. PubMed ID: 34325613
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of Bowman-Birk protease inhibitor on autophagy in MDAMB231 breast cancer cell line.
    Kyani S, Akrami H, Mostafaei A, Akbari S, Salehi Z.
    J Cancer Res Ther; 2021 Aug 01; 17(2):504-509. PubMed ID: 34121699
    [Abstract] [Full Text] [Related]

  • 13. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec 01; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 14. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases.
    Clemente A, Moreno FJ, Marín-Manzano Mdel C, Jiménez E, Domoney C.
    Mol Nutr Food Res; 2010 Mar 01; 54(3):396-405. PubMed ID: 19885848
    [Abstract] [Full Text] [Related]

  • 15. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

  • 16. Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells.
    Billings PC, Brandon DL, Habres JM.
    Eur J Cancer; 1991 Aug 01; 27(7):903-8. PubMed ID: 1834126
    [Abstract] [Full Text] [Related]

  • 17. Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells.
    Kennedy AR, Wan XS.
    Prostate; 2002 Feb 01; 50(2):125-33. PubMed ID: 11816021
    [Abstract] [Full Text] [Related]

  • 18. A serine protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors.
    Billings PC, Carew JA, Keller-McGandy CE, Goldberg AL, Kennedy AR.
    Proc Natl Acad Sci U S A; 1987 Jul 01; 84(14):4801-5. PubMed ID: 3299374
    [Abstract] [Full Text] [Related]

  • 19. Imbibition of soybean seeds in warm water results in the release of copious amounts of Bowman-Birk protease inhibitor, a putative anticarcinogenic agent.
    Palavalli MH, Natarajan SS, Wang TT, Krishnan HB.
    J Agric Food Chem; 2012 Mar 28; 60(12):3135-43. PubMed ID: 22372424
    [Abstract] [Full Text] [Related]

  • 20. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
    Yavelow J, Caggana M, Beck KA.
    Cancer Res; 1987 Mar 15; 47(6):1598-601. PubMed ID: 3545448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.